Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Sweta Vijayan

5 "Strong Buy" Pharmaceutical Stocks to Own for the Long Haul

The inelastic demand for pharmaceutical solutions should help stocks in this space stay afloat amid the current market fluctuations caused by macroeconomic headwinds. Moreover, rising investments in research and development and business collaborations should drive the industry’s growth in the long run.

The global pharmaceuticals market is expected to grow at a 5.9% CAGR to reach $1.40 trillion by 2026. Investors’ interest in this space is evident from the VanEck Vectors Pharmaceutical ETF’s (PPH) 6.3% returns over the past nine months versus the SPDR S&P 500 ETF’s (SPY) 12.2% loss.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.